TY  - JOUR

T1  - Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125.

JO  - Journal of Clinical Oncology

PY  - 1997/01/01

AU  - Rustin GJ

AU  - Nelstrop AE

AU  - Crawford M

AU  - Ledermann J

AU  - Lambert HE

AU  - Coleman R

AU  - Johnson J

AU  - Evans H

AU  - Brown S

AU  - Oster W

ED  - 

DO  - DOI: 10.1200/jco.1997.15.1.172

PB  - American Society of Clinical Oncology (ASCO)

VL  - 15

IS  - 1

SP  - 172

EP  - 176

Y2  - 2025/10/10

ER  -